11 – 18 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2015
-
Mark
Genetic Markers of Insulin Sensitivity and Insulin Secretion Are Associated With Spontaneous Postnatal Growth and Response to Growth Hormone Treatment in Short SGA Children: the North European SGA Study (NESGAS)
(
- Contribution to journal › Article
-
Mark
Biomarkers of rapid chronic kidney disease progression in type 2 diabetes.
(
- Contribution to journal › Article
- 2014
-
Mark
A randomised controlled trial evaluating IGF-I titration in contrast to current GH dosing strategies in children born Small for Gestational Age (NESGAS).
(
- Contribution to journal › Article
-
Mark
Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes
(
- Contribution to journal › Article
- 2013
-
Mark
Baseline IGF-I Levels Determine Insulin Secretion and Insulin Sensitivity during the First Year on Growth Hormone Therapy in Children Born Small for Gestational Age. Results from a North European Multicentre Study (NESGAS)
(
- Contribution to journal › Article
- 2009
-
Mark
Insulin-like growth factor-I, d3-GHR gene polymorphism, prematurity and height at start as determinants of one year growth response during high dose GH; preliminary results from the NESGA study (NESGAS)
(
- Contribution to journal › Published meeting abstract
-
Mark
Phenotypic characteristics of short children born SGA. Baseline data from the North European small for gestational age study (NESGAS)
(
- Contribution to journal › Published meeting abstract
-
Mark
Changes in body composition as assessed by DXA scan after one year of high dose growth hormone treatment in children born SGA. Results from the NESGAS group
(
- Contribution to journal › Published meeting abstract
- « previous
- 1
- 2
- next »